Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients.

CONCLUSION: Among node positive CRC survivors, more than one third of all deaths can be attributed to CRC. Tailored follow up strategies based on baseline risk of each patient need to be established. PMID: 29168934 [PubMed - as supplied by publisher]
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research